Are Biodegradable Third Generation Drug Eluting Stents the Answer to Instent Restenosis?
Amod Amritphale, Nupur Amritphale & Chowdhury H. Ahsan · Cardiology and Angiology: An International Journal · 2014
The third generation biodegradable Drug Eluting Stent (DES) are being evaluated and being introduced in clinical practice. They have been DESigned to overcome limitations associated with durable polymer and a persistent metallic stent scaffold which could be related to late targe...
Open access
Research Article
10.9734/CA/2014/9138